August 2005
Chem. Pharm. Bull. 53(8) 881—885 (2005)
881
Evaluation of Strychnos pseudoquina ST. HIL. Leaves Extract on
Gastrointestinal Activity in Mice
Marcelo Aparecido da SILVA,a,b Bruna Paola Murino RAFACHO,c Clelia Akiko HIRUMA-LIMA,c
Lúcia Regina Machado da ROCHA,c Lourdes Campaner dos SANTOS,a Miriam SANNOMIYA,a
Alba Regina Monteiro SOUZA-BRITO,d and Wagner VILEGAS*,a
a
Departamento de Química Orgânica; Instituto de Química; c.p. 355, CEP 14800–900, UNESP, Araraquara, SP, Brasil:
Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas; CEP 14800–900, UNESP,
Araraquara, SP, Brasil: c Departamento de Fisiologia, Instituto de Biociências; c.p. 510, CEP 18618–000 UNESP,
Botucatu, SP, Brasil: and d Departamento de Fisiologia e Biofísica, Instituto de Biologia; c.p. 6109, CEP 13083–970,
UNICAMP, Campinas, SP, Brasil. Received November 1, 2004; accepted March 25, 2005
b
Strychnos pseudoquina ST. HIL. (Loganiaceae) was investigated for its ability to protect the gastric mucosa
against injuries caused by non-steroidal anti-inflammatory drugs (piroxicam) and a necrotizing agent
(HCl/EtOH) in mice. The MeOH extract and enriched alkaloidic fraction (EAF) provided significant protection
in experimental models wheer used at doses of 250 and 1000 mg/kg. In vivo tests were carried out to evaluate for
possible toxic effects and no mortality was observed up to the 5 g/kg dose level. Phytochemical investigation led to
the isolation of a new indole alkaloid, which elucidated the observed pharmacological effects.
Key words
Strychnos pseudoquina; antiulcer activity; toxic activity; alkaloid
As part of a state collaborative program named BIOTAFapesp, our project entitled “Sustainable use of the Brazilian
Biodiversity: Chemical and Pharmacological Prospection on
Higher Plants” aims to investigate plants with potential activity on the prevention of gastric injuries. This research is
based on ethnopharmacological investigation, followed by
the chemical and pharmacological investigation of plant
extracts. In this work, we investigated the leaves of Strychnos
pseudoquina ST. HIL. (Loganiaceae). Strychnos pseudoquina
is used in traditional medicine for the treatment of malaria
and for the preparation of so-called “aqua inglesa,” largely
used in Brazil as a tonic and febrifuge and also to relieve
stomach pains.1) It is popularly known as “quina branca”
(white quine). Many plants from the genus Strychnos are also
called “quina,” since they are used against malaria.2) Phytochemical investigations of several Strychnos species led to
the isolation of a number of indole alkaloids as the main
compounds. Flavonoids, terpenoids and waxes were also
reported to a lesser extent. Previous investigation of
S. pseudoquina afforded the alkaloids bisnordihydroxytoxiferine, diaboline and 11-methoxydiaboline, as well as the
flavonoids isorhamnetine and estricnobiflavone.1,3) Despite
the well known toxicity of many Strychnos species, our
ethnopharmacological survey indicated that S. pseudoquina
is used as a bitter folk medicine against stomach diseases.
Since Strychnos species are known to contain toxic compounds, it is important to conduct a scientific investigation in
order to assure its efficacy and/or to detect the presence of
toxic components.4)
Results and Discussion
For this phytochemical examination we used an aliquot of
the methanolic extract of leaves from S. pseudoquina. TLC
plates sprayed with Draggendorff, iodoplatinate, and NP/
PEG (Natural Products/Polyethyleneglycol) reagents indicated that this polar extract contained alkaloids and
flavonoids.1,3) This extract was then fractionated by gel permeation chromatography over Sephadex LH-20, and the frac-
tions were purified by adsorption chromatography on silica
or alumina, affording compounds 1—3, which were identified by several spectroscopic methods. After analyses, 2 and
3 were identified as rutin and kempferol 3-O-b -rutinoside.
Compound 1 was identified as a pale yellow gum. The IR
spectrum presented bands at 3300 cm⫺1 (OH) and 1600 cm⫺1
(C⫽C).
The molecular formula of 1 was determined to be
C19H22N2O2 by the EI-MS, which showed pseudo molecular
ion peak sat m/z 311 [M⫹H]⫹ and m/z 333 [M⫹Na]⫹, and
the elemental analysis data. The structure of 1 was fully elucidated by 1D and 2D NMR experiments at 500 MHz. The
1
H-NMR spectrum in CDCl3 (Table 1) displayed signals at d
7.05 (d, J⫽8.0 Hz), 6.71 (dd, J⫽8.0, 8.0 Hz), 7.00 (dd,
J⫽8.0, 8.0 Hz) and 6.57 (d, J⫽8.0 Hz), corresponding to an
ortho-dissubstituted benzene ring. These signals and the signal at d 4.03 suggested the presence of an indolic nucleus.5—7)
The signal at d 6.16 (d, J⫽1.5 Hz) suggested the presence of
a double bond in the structure of 1. The ⬎C⫽CH–CH3 system was deduced from the signal at d 5.54 (q, J⫽6.5 Hz,
⫽CH–) coupled to the doublet at d 1.67 (J⫽6.5 Hz, –CH3) in
the 1H–1H COSY (gradient correlate spectroscopy) spectrum.
Other signals corresponding to the aliphatic chain of 1 were
observed between d 1.97 and 4.03 (Table 1). The 13C-NMR
spectrum presented 19 signals, eight of which could be assigned to the indolic nucleus: d 54.5 (C-7), 65.0 (C-2), 110.6
(C-12), 119.9 (C-10), 122.5 (C-9), 128.8 (C-11), 132.4 (C-8)
and 146.3 (C-13). The signals at d 139.9 (C-16), 124.4 (C17), 124.1 (C-19) and 130.2 (C-20) confirmed the presence
of two double bonds. The presence of the signal at d 91.8 indicated the presence of an additional OH group at position
C-3.6,7) The shielding effects on C-5, C-6 and C-21 when
compared to the literature also support the presence of an
OH-group at C-3.6,7) When compared to the literature, the
deshielding a -effect over C-17 and b -effect over C-16 suggest the presence of an OH-group at C-17.6,7)
The structure of 1 was deduced from a combination of 1D
NOESY (nuclear overhauser effect spectroscopy), 1H–1H-
∗ To whom correspondence should be addressed. e-mail: vilegasw@iq.unesp.br.
© 2005 Pharmaceutical Society of Japan
882
Vol. 53, No. 8
Table 1.
1
H- and 13C-NMR Data of 1 (CDCl3, 500 MHz)
Position
1
H (JHH in Hz)
13
C
COSY
gHMQC
gHMBC
2
3
4.03 (s)
—
65.0
91.8
H2/H17
—
H2/C2
—
5
H5a 2.88 (m); H5b 3.72 (m)
52.4
6
2.21 (m)
39.0
H5a/C5
H5b/C5
H6/C6
7
8
—
—
54.5
132.4
H5a/H5b
H5b/H5a
H6/H5a
H6/H5b
—
—
9
10
7.05 (d, J⫽8.0)
6.71 (dd, J⫽8.0, 8.0)
122.5
119.9
H9/C9
H10/C10
11
7.00 (dd, J⫽8.0, 8.0)
128.8
H11/C11
C11/H9
12
13
6.57 (d, J⫽8.0)
—
110.6
146.3
H9/H10
H10/H11
H10/H9
H11/H12
H11/H10
H12/H11
—
—
C8/H10
C8/H12
C9/H11
C10/H12
H12/C12
—
14
H14a 2.03 (d, J⫽14.5)
H14b 1.97 (dd, J⫽14.5, 9.0)
32.2
C12/H10
C13/H11
C13/H9
—
15
3.43 (d, J⫽9.0)
31.4
16
17
—
6.16 (d, J⫽1.5)
18
19
—
—
H14a/H14b
H14b/H14a
H14b/H15
H14a/H15
H15/H14b
H15/H14a
H14a/C14
H14b/C14
139.6
124.4
—
H17/H2
—
H17/C17
1.67 (dd, J⫽6.0, 1.0)
5.54 (q, J⫽6.0)
13.6
124.1
H18/H19
H19/H18
H18/C18
H19/C19
20
—
130.2
—
—
21
H21a 3.80 (m)
H21b 3.42 (m)
54.1
H21a/H21b
H21b/H21a
H21b/H18
H21a/C21
H21b/C21
COSY, gHMQC (gradient heteronuclear through multiple
quantum coherence) and gHMBC (gradient heteronuclear
multiple bond correlations) experiments, as presented in
Fig. 1. Correlation in the HMBC spectrum between the proton at d 3.80 (H21a) and the carbon at d 91.8 (C-3) supported
the presence of an additional OH-group at C-3, whereas the
long-range correlation between the proton at d 6.16 (H17)
and the carbons at d 139.6 (C-16) and at d 65.0 (C-2) agree
with an OH-group at position C-17.
The structure of 1 is the 3-hydroxy-enolate of the known
alkaloid nordiidrofluorocurarine, previously isolated from S.
amazonica and S. froessi.8) We can pose the question of
whetter compound 1 has a role as a precursor in the biosynthesis of strychnine,9) since 1 seems to be originated just before the formation of the Wieland–Gumlich aldehyde (Fig.
2), but without hydroxylation at positions 3 and 18. It was
already reported that hydroxylation at position 3 can result
from an artifact produced when chlorinated solvents are used
in the extractive processes.10) To check this possibility, we
extracted the leaves of S. pseudoquina with pure MeOH and
with water. TLC analyses using the isolated substance 1 as
standard showed the presence of 1 in both extracts, thus suggesting that 1 is not an artifact.
Although much work has been done on the pharmacological properties and chemical composition of species belong-
Fig. 1.
quina
H15/C15
C2/H17
C3/H21a
C3/H17
—
—
C15/H19
C15/H17
C15/H18
C15/H2
C16/H2
C17/H16
C17/H2
—
C19/H18
C19/H21b
C20/H18
C20/H21a
C21/H19
Indole Alkaloid 1 Isolated from the Leaves of Strychnos pseudo-
ing to the genus Strychnos, only limited data are available in
the literature from the pharmacological and toxicity properties of S. pseudoquina that might ensure the safe use of this
important medicinal plant.
Due to the high cytotoxicity of some of the Strychnos
alkaloids, we first evaluated the crude MeOH extract and the
EAF in in vivo acute toxicity assays in mice. Animals were
treated with a single dose of the MeOH extract and EAF
(5000 mg/kg each) and observed during a period of 14 d. Results showed that there are no significant differences between
the animals treated with saline and those treated with MeOH
or EAF obtained from S. pseudoquina (Fig. 3). In agreement
with this, no signs or symptoms of acute toxicity were observed. There were no significant differences in organ
weight, in water or food intake, or in the amount of faeces
August 2005
883
Fig. 2. Proposed Role of 1 on the Biogenetic Pathway to the Formation of the Wieland–Gumlich Aldehyde in the Biosynthesis of Strychnine (Based on
Dewick, 1997)
Table 3. Effects of the Lansoprazole, MeOH Extract and of the Enriched
Alkaloidic Fraction (EAF) of S. pseudoquina in the Model of HCl/EtOH in
Mice (Mean⫾S.D.)
Dose
(mg/kg)
n
pH
(mean⫾S.D.)
Saline
Lansoprazole
MeOH
10
30
250
1000
7
8
5
5
3.0⫾0.7
6.0⫾0.5**
2.4⫾0.5
2.8⫾1.1
47.0⫾27.6
5.7⫾3.2**
25.2⫾9.7
19.6⫾16.2*
—
87.8
46.4
58.3
Saline
Lansoprazole
EAF
10
30
250
1000
8
8
5
5
2.2⫾0.5
5.5⫾1.3**
3.0⫾0.0
3.0⫾0.0
64.6⫾24.9
2.1⫾2.3**
27.2⫾4.3*
36.4⫾15.1*
—
97.7
57.9
43.7
Treatments
Fig. 3. Body Weight Gain in Mice Treated with Saline, MeOH Extract
and Enriched Alkaloidic Fraction (EAF) of S. pseudoquina (5 g/kg, p.o.)
during 14 d
Table 2. Evaluation of the Acute Toxicity of MeOH Extract and Enriched
Alkaloidic Fraction (EAF) of S. pseudoquina (5 g/kg, p.o.) in Mice
(Mean⫾S.D.)a)
Weight (g)
(n⫽10)
Control
(10 ml/kg)
MeOH
(5 g/kg)
Body
Kidney
Liver
Heart
Lungs
Mortality
41.50⫾7.09
0.52⫾0.12
2.22⫾0.53
0.20⫾0.05
0.27⫾0.04
0/10
40.00⫾3.33
0.51⫾0.14
1.89⫾0.39
0.180⫾0.036
0.27⫾0.04
0/10
ANOVA F(2,27)⫽2.17. Dunnett test ∗ p⬍0.05.
daily administration of MeOH extract and EAF.
EAF
(5 g/kg)
40.50⫾5.98
0.45⫾0.06
1.94⫾0.34
0.17⫾0.31
0.22⫾0.03
0/10
a) Results were obtained 4 d after
produced by treated and control mice (Table 2). None of the
treated mice died during the 14 d of observation after the
administration of the MeOH extract or the EAF. These
results add more information about the possible therapeutic
safety of this species.
The antiulcer activity of the crude MeOH extract and of
ULI
Inhibition
(mean⫾S.D.)
(%)
ANOVA F(4,25) for MeOH⫽6.54 p⬍0.001. Test of Dunnett ∗ p⬍0.05; ∗∗ p⬍0.01;
ANOVA F(4,25) for EAF⫽16.22 p⬍0.001. Test of Dunnett ∗ p⬍0.05; ∗∗ p⬍0.01.
the EAF of S. pseudoquina was then evaluated by two different models. In the model of HCl/EtOH in mice (Table 3),
oral administration of the crude MeOH extract (1000 mg/kg)
significantly inhibited 58.3% of the ulcerogenic lesions from
the HCl/ethanol solution over the gastric surface, whereas the
EAF significantly inhibited 57.9 and 43.7% of the gastric
ulcers at doses of 250 and 1000 mg/kg, respectively.
NSAIDs (non-steroidal anti-inflammatory drugs), such as
piroxicam, resulted in the production of gastric ulcers,
mainly in the glandular portion of the stomach. Nearly 100%
of the animals showed gastric ulceration. The majority of
ulcers were gastric erosions that were multiple, dotted or
elongated superficial haemorrhagic mucosal lesions that did
not penetrate the muscularis mucosae.11) As shown in Table 4,
in the NSAID-induced gastric ulceration model, pretreatment
with crude MeOH extract produced a decrease in the
gastric ulceration induced by piroxicam. The ulcerogenic
lesions caused by piroxicam (Table 4) were significantly
884
Vol. 53, No. 8
Table 4. Effects of the Cimetidine, MeOH Extract and of the Enriched Alkaloidic Fraction (EAF) of S. pseudoquina in the Piroxicam Model in Mice
(Mean⫾S.D.)
Dose
(mg/kg)
n
Saline
Cimetidine
MeOH
10
100
250
1000
7
5
5
5
2.6⫾0.5
3.0⫾0.0
2.6⫾0.5
2.8⫾0.4
21.1⫾6.2
6.0⫾1.6**
8.8⫾4.8**
6.4⫾4.4**
—
68.0
55.5
63.2
Saline
Cimetidine
EAF
10
100
250
1000
8
8
5
5
3.0⫾0.5
3.4⫾0.5
3.0⫾0.0
3.0⫾0.0
31.4⫾9.3
10.0⫾4.8**
9.0⫾2.5**
8.0⫾3.4**
—
68.1
71.2
74.5
Treatments
pH
ULI
Inhibition
(mean⫾S.D.) (mean⫾S.D.)
(%)
ANOVA F(4,22) for MeOH⫽7.11 p⬍0.001. Test of Dunnett ∗∗ p⬍0.01; ANOVA
F(4,26) for EAF⫽20.70 p⬍0.001. Test of Dunnett ∗∗ p⬍0.01.
inhibited by the crude MeOH extract, by 55.5% (250 mg/kg)
and 63.2% (1000 mg/kg). The best results were obtained with
the oral administration of EAF, with significant inhibition of
the ulcerogenic lesions caused by piroxicam by 71.2%
(250 mg/kg) and 74.5% (1000 mg/kg). These results show the
effective antiulcer activity of EAF when compared with
cimetidine treatment (68%), however no significant differences were observed between the groups treated with EAF
and cimetidine (p⬎0.05).
Therefore, our results show that MeOH extract and EAF
from S. pseudoquina are orally effective against gastric damage induced by cytodestructive agents (HCl/ethanol) and ulcerogenic agents (NSAIDs).
The mechanisms by which S. pseudoquina exerts its
antiulcer activity is far from clear. However, EAF in particular is involved in the protection of the stomach against ulceration. It is interesting to observe that the structure of 1
roughly resembles that of omeprazole, a well known antiulcer agent. Literature reports that omeprazole can irreversibly
bind to H⫹/K⫹ ATPase through the sulphydril group.12) However, the irreversible suppression of the gastric pump has
been related to some carcinomas.13) In the case of 1, there is
the possibility of a reversible bond between the alkaloid and
the enzyme, thus revealing the promising potential of 1 as an
anti-ulcer agent (Fig. 4).
In conclusion, this study has shown that both the polar extract and the enriched alkaloid fraction of Strychnos pseudoquina have a significant anti-ulcer and cytoprotective effect
on different experimentally induced gastric lesions, with as
absence of toxicity by acute treatment. Our results show that
the anti-ulcer activity of the MeOH extract is almost as potent as that of the alkaloid-enriched fraction. Therefore, it is
possible that other compounds present in the crude extract
(e.g. flavonoid glycosides) may also contribute to the observed activity. Despite the moderate potency of the extracts
and fractions, the inhibition of gastric damage and absence of
acute toxicity of S. pseudoquina show that the ethnopharmacological approach can be useful in the search for active
extracts and compounds. Further studies are in progress to
evaluate the chronic toxicity and the modes of action.
Experimental
Biological Material The leaves of Strychnos pseudoquina ST. HIL. were
collected in May 2001, at Porto Nacional, Tocantins State, Brazil, and authenticated by Professor Eduardo Ribeiro dos Santos from Instituto de
Biociências (IB), Universidade do Tocantins (UNITINS). A voucher speci-
Fig. 4. Possible Mechanism of Action of 1 Showing the Reversibility of
the Reaction
men (Nr 3291) was deposited at the Herbarium of the UNITINS.
Apparatus NMR spectra in CDCl3 were obtained using a Varian
INOVA-500 spectrometer, operating at 500 MHz for 1H and at 125 MHz for
13
C and 2D-NMR (inverse detection 1H–13C HSQC and HMBC). ES-MS
was performed on a Fisons VG Platform spectrometer in positive (70 V)
mode. The sample was dissolved in MeOH and injected directly. IR spectrum was performed in a FT-IR-Nicolet Impact IMACT-400, KBr. UV spectra were obtained on a Beckman DU 670 spectrometer. Elemental analysis
was made with a Carlo Erba EA 1110 apparatus. TLC was performed on silica gel SiF254 (Merck). The plates were visualized using UV light (254,
365 nm).
Extraction and Isolation The leaves of S. pseudoquina (300 g) were
powdered and successively extracted with CH2Cl2 and MeOH (1 week for
each solvent). The solvents were evaporated in a vacuum to give 13.9 and
17.7 g of each extract, respectively. A portion (5.0 g) of the methylene chloride extract (CH2Cl2) was repeatedly fractionated by column chromatography on silica gel eluted with several gradient mixtures of hexane/EtOAc to
give lupeol, a -amirin and b -amirin, identified by their NMR data compared
to the literature,14) and also by GC-FID analyses with authentic standards. A
portion (5.0 g) of the methanolic extract (MeOH) of S. pseudoquina was
submitted to column chromatography on Sephadex LH-20 (100⫻5 cm) with
MeOH as the eluent. One hundred fractions (5 ml) were collected and
checked by TLC on silica gel plates CHCl3–MeOH–n-PrOH–H2O
(5 : 6 : 1 : 4, v/v/v/v lower phase) was revealed with Draggendorff, iodoplatinate or NP/PEG (Natural Products/Polyethyleneglycol) reagents. Alkaloids
were detected in Fr. 3—29 (named “enriched alkaloidic fraction (EAF)” ca.
3 g) and flavonoids were detected in Fr. 35—90 (250 mg). Fractions 23—25
(69.8 mg) were further purified by column chromatography on neutral
alumina using CHCl3–MeOH–NH4OH (95.0 : 0.5 : 0.05, v/v/v) as an eluent
to afford the alkaloid 1 (20 mg). Fractions 35—37 (40 mg) and fractions
40—42 (45 mg) were purified by repeated column chromatography on
polyvinylpolypyrrolidone (Sigma) eluted with MeOH, yielding 2 (9.0 mg)
and 3 (7.0 mg), respectively. Compounds 2 and 3 were identified by their
NMR spectra and by comparison with previous data reported in the literature.15,16)
Compound 1 IR (KBr): 3300 cm⫺1 (OH), 1600 cm⫺1 (C⫽C). ES-MS
m/z (rel. int.) (70 V, positive ion): 311 (100) [M⫹H]⫹, 333 (30) [M⫹Na]⫹.
Elemental analysis: Anal. C 73.45%, H 7.24%, N 9.15% Calcd for
C19H22N2O2 C 73.52%, H 7.14%, N 9.03%. 1H- and 13C-NMR: see Table 1.
Animals Male Swiss albino mice (25—35 g) from the Central Animal
House of the Universidade Estadual Julio de Mesquita Filho (UNESP/Botucatu) were used. The animals were fed a certified Nuvilab CR-a® (Nuvital)
August 2005
diet with free access to tap water under standard conditions of 12 h
dark–12 h light and temperature (22⫾1%). Fasting was done prior to all assays because the standard drugs and extract were always administered orally
(by gavage). Moreover, the animals were kept in cages with raised floors of
wide wire mesh to prevent coprophagy. The protocols were approved by the
UNESP Institutional Animal Care and Use Committee, following the recommendations of the Canadian Council on Animal Care.17)
Drugs and Chemicals HCl, EtOH (Nuclear, Brazil), cimetidine (Sigma
Chemical Co., St. Louis, MO, U.S.A.), piroxicam (Hexal, Brazil) and lansoprazole (Medley, Brazil) were used in this study. Each extract was dissolved
in NaCl solution 0.9% (vehicle). All substances were prepared immediately
before use, and the reagents used were of analytical grade.
Hippocratic Screening and Acute Toxicity The signs and symptoms
associated with the oral administration of the MeOH extract and of the EAF
(5000 mg/kg, each) were monitored in 8 mice per dose. The mice were examined 0, 0.5, 1, 2, 4, 8, 24 and 48 h after administration to assess possible
clinical or toxicological symptoms. The mortality rate was monitored for a
period of 2 weeks.18)
Antiulcerogenic Effect a) HCl/EtOH-Induced Ulcer: The antiulcerogenic activity of the extract obtained from S. pseudoquina was studied in
HCl/EtOH-induced gastric ulcer. The experiment was performed as described in the literature.19) Mice were divided into groups of 7—8 animals
which were fasted 24 h prior to receiving an oral dose of the vehicle, saline
(10 ml/kg), lanzoprazole (30 mg/kg) or S. pseudoquina (250, 1000 mg/kg).
After 50 min all groups were orally treated with 0.2 ml of a 0.3 M HCl/60%
EtOH solution (HCl/EtOH) for gastric-ulcer induction. Animals were killed
1 h after the administration of HCl/EtOH, and the stomachs excised and inflated by saline injection (2 ml). The extent of the lesions was measured
using an ulcerative lesion index (ULI), and the pH of gastric juice determined. This index was expressed as the sum of all lesions, as described in
the literature.20)
b) Non-steroidal Antiinflammatory Drug (NSAID)-Induced Gastric Ulcers in Mice: In this model,21) gastric ulcer was induced using piroxicam
(30 mg/kg, s.c.) administered to mice. The crude MeOH extract or EAF
from S. pseudoquina (250, 1000 mg/kg), cimetidine (100 mg/kg) or saline
was administered orally 30 min before induction of the gastric ulcer. The animals were killed by cervical dislocation 4 h after treatment with the ulcerogenic agent; the stomachs were removed and the gastric juice pH and gastric
damage were determined by the ULI calculated as described previously.
Statistical Analysis Results ware expressed as the mean⫾S.D. Statistical significance was determined by one-way analysis of variance followed by
Dunnett’s test, with the level of significance set at p⬍0.05.
Acknowledgements We thank Fundação de Amparo à Pesquisa do Es-
885
tado de São Paulo (FAPESP) for a grant to D.R and M.S, the Biota-Fapesp
Program for funding and Conselho Nacional de Desenvolvimento Científico
Tecnológico (CNPq) for grants to W.V. and A.R.M.S.B.
References
1) Nicoletti M., Goulart M. O. F., Delima R. A., Goulart A. E., DelleMonache F., Bettolo G. B. M., J. Nat. Prod., 47, 953—957 (1984).
2) Correa P. M., “Dicionário das Plantas Úteis do Brasil e das Exóticas
Cultivadas,” 1st ed., Vol. VI, Imprensa Oficial, Rio de Janeiro, 1926.
3) Delle-Monache F., Aldo P. T., Bettolo G. B. M., Tetrahedron Lett., 25,
2009—2012 (1969).
4) Angenot L., Quertim-Leclercq J., Bisset N. G., J. Ethnopharmacol.,
28, 1—52 (1990b).
5) Penelle J., Monique T., Philippe C., Viviane B., Michel F., Angenot L.,
J. Nat. Prod., 62, 898—900 (1999).
6) Wenkert E., Andrew C. H. T., Gottlieb H. H. J., Org. Chem., 43,
1099—1105 (1978).
7) Verpoorte R., Bisset N. G., Hylands J. P., Org. Magn. Reson., 9, 567—
571 (1977).
8) Angenot L., Belem P. M. L., Imbiriba R. A. F., Poukens R. P., QuetimLeclercq J., Warin R., Phytochemistry, 29, 2746—2749 (1990a).
9) Dewick P. M., “Medicinal Natural Products: A Biosynthetic Approach,” John Wiley & Sons Ltd., Baffins Lane, England, 1997.
10) Bisset N. G., Phillipson D. J., Phytochemistry, 11, 2547—2553 (1972).
11) Al-Shabanah O. A., Food Chem. Toxicol., 35, 769—775 (1997).
12) Richardson P., Hawkey C. J., Stack W. A., Drugs, 56, 307—335
(1998).
13) Witiak D. T., Braghiroli D., Bella D. M., “Antiallergic and Antiulcer
Drugs,” Chap. 20, ed. by Foye O. W., Lemke L. T., Williams A. D.,
Williams & Wilkins, Hong Kong, 1995, pp. 435—441.
14) Shashi B. M., Asish P. K., Phytochemistry, 37, 1517—1575 (1994).
15) Harborne J. B., “The Flavonoids. Advances in Research Since 1986,”
1st ed., Chapman and Hall, London, 1993.
16) Agrawal P. K., “Carbon 13 NMR of Flavonoids,” 1st ed., Vol. XXXIX,
Elsevier, Amsterdam, 1989.
17) Olfert E. D., Cross B. M., McWilliam A. A., “Guide to the Care and
Use of Experimental Animals,” 2nd ed., Vol. I, Canadian Council on
Animal Care, Ottawa, Ontario, 1993.
18) Souza-Brito A. R., “Manual de ensaios toxicológicos in vitro,” 1st ed.,
Editora da UNICAMP, Campinas, São Paulo, 1994.
19) Mizui T., Doteuchi M., Jpn. J. Pharmacol., 33, 939—945 (1983).
20) Szelenyi I., Thiemer K., Arch. Toxicol., 41, 99—104 (1978).
21) Puscas I., Puscas C., Pasca R., Arzneimittelforschung, 47, 568—572
(1997).